Gut Bacterium Akkermansia Muciniphila Blocks Salmonella From Sticking to Intestinal Lining
In mice, Akkermansia muciniphila reduced Salmonella colonization and colitis by inhibiting the pathogen's adhesion to gut epithelium, hinting at probiotic potential.
Résumé
Salmonella Typhimurium is a common food-borne pathogen that causes gastroenteritis. Researchers asked whether Akkermansia muciniphila, a mucin-degrading gut bacterium, could protect against it. Using germ-free mice colonized with defined simplified human or mouse microbiota communities, they infected animals with an attenuated Salmonella strain, with or without added A. muciniphila. Mice carrying A. muciniphila had lower Salmonella colonization, milder colitis, better tissue histology, and lower inflammatory cytokines. Live A. muciniphila also reduced Salmonella adhesion to the gut lining in mice and to cultured mucus-producing human epithelial cells. The findings suggest A. muciniphila protects mainly by interfering with pathogen attachment. This is preclinical work in controlled mouse models, so human benefit remains unproven.
Résumé détaillé
Salmonella Typhimurium is a leading cause of food-borne gastroenteritis, and the gut microbiota normally helps resist infection. Akkermansia muciniphila, a mucin-degrading bacterium associated with metabolic and gut health, has drawn interest as a next-generation probiotic, yet its role in enteric infection has been unclear.
The researchers used gnotobiotic mice, which carry only a defined set of microbes. Animals were colonized with either a simplified human microbiota (SIHUMI) or a mouse microbiota (OMM11), with or without A. muciniphila, and then infected with an attenuated S. Typhimurium ΔaroA strain. They also tested adhesion in differentiated, polarized HT29-MTX-E12 human epithelial cells.
Mice with A. muciniphila had lower intestinal Salmonella colonization. Salmonella-induced colitis was significantly reduced, with improved histopathology and lower inflammatory cytokines. Viable A. muciniphila inhibited Salmonella adhesion to the intestinal epithelium in vivo and in the cell model, pointing to blocked attachment as a central protective mechanism.
The results support A. muciniphila as a candidate for strategies to limit enteric infection and inflammation, and they highlight competition for the mucosal niche as a way commensals provide colonization resistance. The title also mentions intestinal fibrosis, but the abstract provides no fibrosis data, so that aspect cannot be assessed here.
Important caveats: the work relies on gnotobiotic mice with simplified microbiota and an attenuated Salmonella strain, which may not reflect the complexity of human infection or a full microbiome. Only the abstract was available, so details on effect sizes, statistics, and mechanisms are unknown. Human trials are needed before any clinical recommendations.
Principales conclusions
- A. muciniphila presence reduced intestinal Salmonella Typhimurium colonization in gnotobiotic mice with defined human or mouse microbiota.
- Salmonella-induced colitis was significantly milder with A. muciniphila, including improved histopathology.
- Inflammatory cytokine levels were lower in infected mice colonized with A. muciniphila.
- Viable A. muciniphila inhibited Salmonella adhesion to intestinal epithelium in vivo and in HT29-MTX-E12 cells.
- Blocking pathogen adhesion appears to be a key protective mechanism.
Méthodologie
Gnotobiotic mice colonized with defined simplified human (SIHUMI) or mouse (OMM11) microbiota, with or without A. muciniphila, were infected with attenuated S. Typhimurium ΔaroA. Outcomes included pathogen colonization, histopathology, and cytokines, and adhesion was tested in vivo and in polarized HT29-MTX-E12 epithelial cells.
Limites de l'étude
The study is preclinical, using simplified gnotobiotic mouse microbiota and an attenuated Salmonella strain that may not reflect human disease. Only the abstract was reviewed, so quantitative details are unavailable, and the fibrosis finding in the title is not described in the abstract.
Ce résumé vous a plu ?
Recevez les dernières recherches sur la longévité dans votre boîte de réception chaque semaine.
Saisissez votre e-mail pour vous abonner :